Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

sm1

  • Home
  •  
  • sm1



  • Most Read
  • Latest Comments
  • Synlait receives permit renewal to supply baby formula to the Chinese market
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Synlait receives permit renewal to supply baby formula to the Chinese market
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Synlait receives permit renewal to supply baby formula to the Chinese market
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Synlait receives permit renewal to supply baby formula to the Chinese market
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Synlait receives permit renewal to supply baby formula to the Chinese market
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Bubs enrols 400th infant in its US clinical trials to get baby formula approval
    Bubs enrols 400th infant in its US clinical trials to get baby formula approval
    • News

  • Softer infant formula demand in Middle East, China and EU squeeze Clover’s profits
    Softer infant formula demand in Middle East, China and EU squeeze Clover’s profits
    • News

  • Bubs presents its rebound plan after bitter breakup with former CEO and Chairman
    Bubs presents its rebound plan after bitter breakup with former CEO and Chairman
    • News

  • Investing basics: Be an empowered and informed shareholder by understanding your rights
    Investing basics: Be an empowered and informed shareholder by understanding your rights
    • Explainers

  • Synlait receives permit renewal to supply baby formula to the Chinese market
    Synlait receives permit renewal to supply baby formula to the Chinese market
    • News

  • Synlait receives permit renewal to supply baby formula to the Chinese market
    • News

    Synlait receives permit renewal to supply baby formula to the Chinese market

    China has emerged as a hotspot for baby formula export from Australia and New Zealand. Imported baby formula holds a significant 56% share of the total market, making it one of the leading export commodities from both countries. These imported formulas will be valued at an estimated US$32 billion by 2023, according to Euromonitor, driven

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.